AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 11 min read$FUL

Director at H.B. Fuller (NYSE: FUL) receives new stock award

H.B. Fuller (FUL) director Teresa J. Rasmussen Trangsrud received 1,171.25 stock units valued at $56.35 each, convertible to common stock 1-for-1 upon certain events. She now holds 26,122.92 stock units and 3,391.433 common shares. The award is part of the company's deferred compensation plan.

Original reporting
stocktitan.net
Published Sep 1, 2026, 4:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$FUL
Neutral
high confidence
Mentioned
$FUL
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$FULNeutralLow
01

Why it matters

The award is a routine compensation event with limited market impact.

02

Market read

Minor insider compensation event; unlikely to influence trading decisions.

03

What to watch

Potential future dilution if many directors hold similar awards, but current impact remains minimal.

Relevance 4/10Novelty 5/10Timing: filing date 2026-08-28

Background

Form 4 filing discloses a director's stock unit award and current holdings.

Company-level read

Ticker impact

$FULNeutralHigh confidence
Context

Director Teresa J. Rasmussen Trangsrud received a grant of 1,171.25 stock units valued at $56.35 per unit on 2026-08-28, increasing her holdings to 26,122.92 units.

Expected impact

Minimal impact; no significant price change expected.

Evidence & confidence

The award is a routine compensation grant for a director, valued at about $66k, which is insignificant relative to market cap and typical trading volume.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Even small insider grants can signal confidence from the board, but the amount is too trivial to affect valuation.

Key entities

  • Company
    H.B. Fuller

    Manufacturer of adhesives and specialty chemicals.

  • Individual
    Teresa J. Rasmussen Trangsrud

    Director at H.B. Fuller receiving the stock unit award.

Read at source← All news

Related articles

AUG 24
$FULMedAI 8/10

H.B. Fuller board rejects unsolicited bid

H.B. Fuller's board rejected an unsolicited bid for its BAS segment, citing a valuation below market precedent and lack of financing details. The board highlighted BAS's 6% organic growth and 10% EBITDA improvement, noting its importance for future earnings. The board also cited operational integration challenges and reaffirmed its strategic priorities, including the Advanced Medical Solutions acquisition and Project Quantum Leap.

european-coatings.com1 min
AUG 24
$FULMedAI 8/10

H.B. Fuller stock flat as board rejects Ancora’s adhesives bid

H.B. Fuller Co. (NYSE:FUL) shares were unchanged in premarket trading after its board rejected Ancora Holdings Group's $1.2 billion bid for its building adhesives unit, citing undervaluation and lack of growth potential consideration. Ancora criticized the rejection as irrational and emphasized its ability to finance a higher offer. The bid aimed to help H.B. Fuller reduce debt and focus on integrating Advanced Medical Solutions Group Plc.

investing.com1 min
AUG 13
$FULMed

AMS shareholders approve H.B. Fuller acquisition proposal

H.B. Fuller (NYSE:FUL) said Advanced Medical Solutions Group plc (LSE:AMS) shareholders approved the proposed cash acquisition of AMS. The approval is a milestone toward closing, which H.B. Fuller expects by year end, subject to remaining conditions and regulatory approvals. H.B. Fuller reported 2025 revenue of $3.5B.

investing.com2 min
AUG 12
$FULMed

Ancora offers up to $1.2bn for an H.B. Fuller business

Activist investor Ancora Holdings proposes an all-cash offer of up to $1.2bn to buy H.B. Fuller’s Building Adhesive Solutions unit, urging divestiture and offering to start due diligence. Ancora, holding over 2% of shares, says it has received no substantive response and may seek board control via a proxy fight. H.B. Fuller shares were down 2.3% intraday.

marketscreener.com4 min